Selecta Biosciences

$1.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.55%) As of 2:47 PM EDT today
-$0.01 (-0.55%) Today

Why Robinhood?

You can buy or sell SELB and other stocks, options, ETFs, and crypto commission-free!

About SELB

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. it produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. Read More The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Employees
39
Headquarters
Watertown, Massachusetts
Founded
2007
Market Cap
81.83M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
108.60K
High Today
$1.86
Low Today
$1.79
Open Price
$1.79
Volume
11.48K
52 Week High
$16.55
52 Week Low
$1.41

Collections

SELB News

ReutersAug 10

Edited Transcript of SELB earnings conference call or presentation 8-Aug-19 12:30pm GMT

27

SELB Earnings

-$0.88
-$0.69
-$0.49
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, Pre-Market

More SELB News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.